1-3 of 3
Sarah Kolla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial of Vorinostat (SAHA) in Combination with Alvocidib (Flavopiridol) in Patients with Relapsed, Refractory or (Selected) Poor Prognosis Acute Leukemia or Refractory Anemia with Excess Blasts-2 (RAEB-2)

Steven Grant, MD, Sarah Kolla, Leonardo Andres Sirulnik, MD, PhD, Geoffrey Shapiro, Jeffrey Supko, Brenda Cooper, Edward Perkins, Viswanathan Ramakrishnan, Igor Espinoza-Delgado, MD, M B Tombes, John D Roberts
Journal: Blood
Blood (2008) 112 (11): 2986.
https://doi.org/10.1182/blood.V112.11.2986.2986
Published: 2008
Journal Articles

Phase I Trial of Bortezomib (NSC 681239) and Flavopiridol (NSC 649890) in Patients with Recurrent or Refractory Indolent B-Cell Neoplasms.

Steven Grant, MD, Daniel Sullivan, David Roodman, MD, PhD, Robert K Stuart, MD, Edward Perkins, Sarah Kolla, Viswanathan Ramakrishnan, John Wright, MD, PhD, Alexander Dimitri Colevas, M B Tombes, John D Roberts
Journal: Blood
Blood (2008) 112 (11): 1573.
https://doi.org/10.1182/blood.V112.11.1573.1573
Published: 2008
Journal Articles

CCAAT Displacement Protein (CDP/cut) Recognizes a Silencer Element Within the Lactoferrin Gene Promoter

Arati Khanna-Gupta, Theresa Zibello, Sarah Kolla, Ellis J. Neufeld, Nancy Berliner
Journal: Blood
Blood (1997) 90 (7): 2784–2795.
https://doi.org/10.1182/blood.V90.7.2784
Published: 1997